By Michele Maatouk
Date: Monday 18 Mar 2024
LONDON (ShareCast) - (Sharecast News) - Consumer healthcare company Haleon said on Monday that Pfizer plans to sell around 630m shares in the company in a public offering.
The sale will reduce Pfizer's stake from 32% to approximately 24%.
Haleon - which was spun off from GSK - said the offer price per share will be determined by means of a bookbuilding process and is expected to be announced on or about 19 March, following completion.
Pfizer had said in May 2023 that it was planning to cut its stake in Haleon in a "slow and methodical" manner.
Email this article to a friend
or share it with one of these popular networks: